Complete right bundle branch block predicts mortality in Thai patients with chronic heart failure with reduced

Wanwarang Wongcharoen1, Arintaya Phrommintikul, Rungsrit Kanjanavanit

  • 1Department of lnternal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Insights

In heart failure patients, right bundle branch block (RBBB) independently predicts mortality, unlike left bundle branch block (LBBB). This study clarifies the prognostic significance of different bundle branch blocks in Thai heart failure with reduced ejection fraction (HFrEF) patients.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Intraventricular conduction defects are linked to increased mortality in heart failure (HF).
  • The comparative prognostic value of left bundle branch block (LBBB) versus right bundle branch block (RBBB) in HF populations remains debated.

Purpose of the Study:

  • To assess the association between bundle branch block (BBB) patterns and all-cause mortality in Thai patients with chronic heart failure with reduced ejection fraction (HFrEF).
  • To compare the predictive capabilities of RBBB and LBBB for mortality in this specific patient cohort.

Main Methods:

  • Retrospective cohort study of 170 HFrEF patients requiring hospitalization.
  • Follow-up in a heart failure clinic, with mortality predictors analyzed using Cox proportional hazard analysis.

Main Results:

  • 26% of patients had wide QRS complex (≥120 ms), including 15% with LBBB and 11% with RBBB.
  • During a mean follow-up of 1.8 years, 13% of patients died.
  • Univariate analysis identified RBBB, chronic renal insufficiency, COPD, and severe LV systolic dysfunction as mortality predictors. Multivariate analysis confirmed RBBB as the sole independent predictor (OR 3.9, p<0.05).

Conclusions:

  • Right bundle branch block (RBBB) is the only independent predictor of mortality in Thai patients with HFrEF.
  • These findings highlight the importance of identifying RBBB in HFrEF patients for risk stratification.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure Drugs: &#946;-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...